Theranostics 2019; 9(3):868-883. doi:10.7150/thno.29381 This issue Cite

Research Paper

Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re

José Carlos De La Vega1, Pedro Luis Esquinas2, Cristina Rodríguez-Rodríguez1,3, Mehrdad Bokharaei1, Igor Moskalev4, David Liu5, Katayoun Saatchi1✉, Urs O. Häfeli1✉

1. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC Canada;
2. Department of Radiology, University of British Columbia, Vancouver, BC Canada;
3. Department of Physics and Astronomy, University of British Columbia, Vancouver, BC Canada;
4. The Vancouver Prostate Cancer Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC Canada;
5. Department of Interventional Radiology, Vancouver General Hospital, Vancouver, BC Canada.

Citation:
De La Vega JC, Esquinas PL, Rodríguez-Rodríguez C, Bokharaei M, Moskalev I, Liu D, Saatchi K, Häfeli UO. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re. Theranostics 2019; 9(3):868-883. doi:10.7150/thno.29381. https://www.thno.org/v09p0868.htm
Other styles

File import instruction

Abstract

Graphic abstract

A common form of treatment for patients with hepatocellular carcinoma (HCC) is transarterial radioembolization (TARE) with non-degradable glass or resin microspheres (MS) labeled with 90Y (90Y-MS). To further simplify the dosimetry calculations in the clinical setting, to have more control over the particle size and to change the permanent embolization to a temporary one, we developed uniformly-sized, biodegradable 188Re-labeled MS (188Re-MS) as a new and easily imageable TARE agent.

Methods: MS made of poly(L-lactic acid) were produced in a flow focusing microchip. The MS were labeled with 188Re using a customized kit. An orthotopic HCC animal model was developed in male Sprague Dawley rats by injecting N1-S1 cells directly into the liver using ultrasound guidance. A suspension of 188Re-MS was administered via hepatic intra-arterial catheterization 2 weeks post-inoculation of the N1-S1 cells. The rats were imaged by SPECT 1, 24, 48, and 72 h post-radioembolization.

Results: The spherical 188Re-MS had a diameter of 41.8 ± 6.0 µm (CV = 14.5%). The site and the depth of the injection of N1-S1 cells were controlled by visualization of the liver in sonograms. Single 0.5 g tumors were grown in all rats. 188Re-MS accumulated in the liver with no deposition in the lungs. 188Re decays to stable 188Os by emission of β¯ particles with similar energy to those emitted by 90Y while simultaneously emitting γ photons, which were imaged directly by single photon computed tomography (SPECT). Using Monte Carlo methods, the dose to the tumors was calculated to be 3-6 times larger than to the healthy liver tissue.

Conclusions: 188Re-MS have the potential to become the next generation of β¯-emitting MS for TARE. Future work revolves around the investigation of the therapeutic potential of 188Re-MS in a large-scale, long-term preclinical study as well as the evaluation of the clinical outcomes of using 188Re-MS with different sizes, from 20 to 50 µm.

Keywords: radioembolization, liver cancer, microspheres, monosized, 188Re, beta radiation therapy


Citation styles

APA
De La Vega, J.C., Esquinas, P.L., Rodríguez-Rodríguez, C., Bokharaei, M., Moskalev, I., Liu, D., Saatchi, K., Häfeli, U.O. (2019). Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re. Theranostics, 9(3), 868-883. https://doi.org/10.7150/thno.29381.

ACS
De La Vega, J.C.; Esquinas, P.L.; Rodríguez-Rodríguez, C.; Bokharaei, M.; Moskalev, I.; Liu, D.; Saatchi, K.; Häfeli, U.O. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re. Theranostics 2019, 9 (3), 868-883. DOI: 10.7150/thno.29381.

NLM
De La Vega JC, Esquinas PL, Rodríguez-Rodríguez C, Bokharaei M, Moskalev I, Liu D, Saatchi K, Häfeli UO. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re. Theranostics 2019; 9(3):868-883. doi:10.7150/thno.29381. https://www.thno.org/v09p0868.htm

CSE
De La Vega JC, Esquinas PL, Rodríguez-Rodríguez C, Bokharaei M, Moskalev I, Liu D, Saatchi K, Häfeli UO. 2019. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re. Theranostics. 9(3):868-883.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image